Phase I/II Study of Celebrex and EPO906 in Patients with Metastatic Colorectal Cancer (CEPO906AUS10).
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Patupilone (Primary) ; Celecoxib
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions
- 23 Jun 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated
- 25 Mar 2015 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.